Contributors |
|
xxi | |
Foreword |
|
xxxiii | |
Preface |
|
xxxv | |
|
1 Essentials of the COVID-19 coronavirus |
|
|
1 | (26) |
|
|
|
|
|
1 | (2) |
|
|
3 | (2) |
|
3 Revealed essential features of COVID-19 coronavirus |
|
|
5 | (22) |
|
|
22 | (1) |
|
|
22 | (5) |
|
2 Docking study of transmembrane serine protease type 2 inhibitors for the treatment of COVID-19 |
|
|
27 | (14) |
|
|
|
27 | (1) |
|
|
28 | (2) |
|
|
30 | (2) |
|
|
32 | (5) |
|
|
37 | (4) |
|
|
37 | (2) |
|
|
39 | (2) |
|
3 Gut-lung cross talk in COVID-19 pathology and fatality rate |
|
|
41 | (20) |
|
|
|
|
|
41 | (1) |
|
2 Adult human gut microbiota |
|
|
42 | (1) |
|
3 Respiratory tract microbiota |
|
|
43 | (1) |
|
4 Gut-lung cross talk during viral COVID-19 |
|
|
44 | (2) |
|
5 Suggested COVID-19 intervention strategies through the use of probiotics and prebiotics |
|
|
46 | (3) |
|
6 The role of probiotic in ventilator-associated pneumonia |
|
|
49 | (12) |
|
|
51 | (10) |
|
4 Data sharing and privacy issues arising with COVID-19 data and applications |
|
|
61 | (16) |
|
|
|
|
|
61 | (1) |
|
2 The process of accelerating COVID-19 research |
|
|
62 | (2) |
|
3 Medical data and sharing |
|
|
64 | (3) |
|
4 COVID-19 applications and privacy |
|
|
67 | (6) |
|
5 Discussion and suggestions for further research |
|
|
73 | (4) |
|
|
74 | (3) |
|
5 COVID-19 outlook in the United States of America: a data-driven thematic approach |
|
|
77 | (18) |
|
|
|
|
|
77 | (1) |
|
|
78 | (3) |
|
|
81 | (2) |
|
|
83 | (6) |
|
|
89 | (1) |
|
|
90 | (5) |
|
|
91 | (4) |
|
6 Artificial intelligence and COVID-19: fighting pandemics |
|
|
95 | (18) |
|
|
|
|
95 | (2) |
|
2 Phases for fighting pandemics |
|
|
97 | (6) |
|
3 Present artificial intelligence efforts for fighting COVID-19 |
|
|
103 | (3) |
|
4 Ethical use of artificial intelligence while fighting COVID-19 |
|
|
106 | (1) |
|
5 Ongoing lessons from COVID-19 |
|
|
107 | (1) |
|
|
108 | (5) |
|
|
110 | (3) |
|
7 Data science: a survey on the statistical analysis of the latest outbreak of the 2019 pandemic novel coronavirus disease (COVID-19) using ANOVA |
|
|
113 | (28) |
|
|
|
|
|
|
|
113 | (2) |
|
|
115 | (6) |
|
|
121 | (1) |
|
|
121 | (9) |
|
5 Outbreak of COVID-19, as of March 31, 2020 |
|
|
130 | (2) |
|
6 Outbreak of COVID-19, as of April 25, 2020 |
|
|
132 | (3) |
|
7 Comparison of COVID-19 in March and April |
|
|
135 | (1) |
|
|
136 | (5) |
|
|
136 | (5) |
|
8 Application of big data in COVID-19 epidemic |
|
|
141 | (26) |
|
|
|
|
Roseline Oluwaseun Ogundokun |
|
|
|
141 | (3) |
|
2 The growth of data in healthcare |
|
|
144 | (8) |
|
3 Big data privacy and ethical challenges in COVID-19 |
|
|
152 | (2) |
|
4 Big data analytics in COVID-19 epidemic |
|
|
154 | (4) |
|
|
158 | (9) |
|
|
159 | (8) |
|
9 Artificial intelligence-based solutions for COVID-19 |
|
|
167 | (24) |
|
|
|
|
|
|
|
|
|
|
167 | (7) |
|
2 Technologic solutions to help combat the COVID-19 outbreak |
|
|
174 | (11) |
|
3 Limitations and future scope |
|
|
185 | (6) |
|
|
187 | (4) |
|
10 Telemedicine applications for pandemic diseases, with a focus on COVID-19 |
|
|
191 | (18) |
|
|
|
|
|
|
191 | (2) |
|
2 Telemedicine applications during epidemic/pandemic |
|
|
193 | (2) |
|
3 Telemedicine applications for COVID-19 |
|
|
195 | (6) |
|
|
201 | (2) |
|
5 Conclusions and future work |
|
|
203 | (6) |
|
|
203 | (1) |
|
|
204 | (5) |
|
11 Impact of COVID-19 and lockdown policies on farming, food security, and agribusiness in West Africa |
|
|
209 | (16) |
|
|
|
|
|
|
|
|
209 | (3) |
|
|
212 | (2) |
|
|
214 | (5) |
|
|
219 | (2) |
|
5 Conclusion and recommendations |
|
|
221 | (4) |
|
|
222 | (1) |
|
|
222 | (3) |
|
12 Study and impact analysis of COVID-19 pandemic clinical data on infection spreading |
|
|
225 | (18) |
|
|
|
|
|
|
|
225 | (3) |
|
|
228 | (2) |
|
|
230 | (4) |
|
|
234 | (4) |
|
5 Proposed model for the prediction of COVID-19 |
|
|
238 | (2) |
|
6 Conclusion and future scope |
|
|
240 | (3) |
|
|
240 | (3) |
|
13 Toward analyzing the impact of healthcare treatments in industry 4.0 environment---a self-care case study during COVID-19 outbreak |
|
|
243 | (14) |
|
|
|
|
|
|
|
243 | (5) |
|
2 Case study: experimental simulation, results, and analysis |
|
|
248 | (5) |
|
|
253 | (4) |
|
|
254 | (1) |
|
|
254 | (1) |
|
|
254 | (1) |
|
|
254 | (1) |
|
|
255 | (2) |
|
14 Big data processing and analysis on the impact of COVID-19 on public transport delay |
|
|
257 | (22) |
|
|
|
|
|
257 | (2) |
|
|
259 | (4) |
|
|
263 | (7) |
|
|
270 | (5) |
|
5 Conclusion and future work |
|
|
275 | (4) |
|
|
276 | (3) |
|
15 The role of societal research and centers in analyzing society in pandemic times |
|
|
279 | (20) |
|
|
|
|
|
|
|
|
|
|
279 | (2) |
|
|
281 | (2) |
|
|
283 | (12) |
|
|
295 | (1) |
|
5 Conclusions and suggestions/future work |
|
|
295 | (4) |
|
|
296 | (3) |
|
16 Modeling and predicting the spread of COVID-19: a continental analysis |
|
|
299 | (20) |
|
|
|
|
|
|
|
|
|
|
299 | (2) |
|
2 A continental review of modeling and prediction studies |
|
|
301 | (2) |
|
|
303 | (9) |
|
|
312 | (7) |
|
|
313 | (6) |
|
17 Applications of Building Information Modeling for COVID-19 spread assessment due to the organization of building artifacts |
|
|
319 | (16) |
|
|
|
|
|
|
319 | (2) |
|
2 Summarizing the applications of Building Information Modeling for CSAOBA |
|
|
321 | (4) |
|
3 An add-in tool for building-level communal spread due to seating arrangements within a room |
|
|
325 | (1) |
|
|
326 | (4) |
|
|
330 | (1) |
|
|
330 | (5) |
|
|
331 | (4) |
|
18 COVID-19 diagnosis---myths and protocols |
|
|
335 | (20) |
|
|
|
|
|
|
|
|
335 | (1) |
|
|
336 | (13) |
|
|
349 | (6) |
|
|
349 | (6) |
|
19 "Quarantined within a quarantine": COVID-19 and GIS Dynamic Scenario Modeling in Tasmania, Australia |
|
|
355 | (42) |
|
|
|
|
|
|
|
Mozhdeh Rostemnezhad Cherati |
|
|
|
355 | (2) |
|
2 Managing pandemics with data science and technology |
|
|
357 | (2) |
|
|
359 | (17) |
|
|
376 | (4) |
|
5 Tasmania COVID-19 spread: systems dynamic modeling |
|
|
380 | (5) |
|
6 North West Tasmania emergency response and recovery dynamic scenario modeling |
|
|
385 | (2) |
|
7 Conclusions and future work |
|
|
387 | (10) |
|
|
388 | (1) |
|
|
389 | (8) |
|
20 Essentials of COVID-19 and treatment approaches |
|
|
397 | (26) |
|
|
|
|
397 | (1) |
|
2 History and epidemiology |
|
|
398 | (2) |
|
3 Structure of SARS-CoV-2 |
|
|
400 | (1) |
|
|
401 | (3) |
|
|
404 | (11) |
|
6 Various approaches to design vaccine |
|
|
415 | (2) |
|
|
417 | (6) |
|
|
417 | (6) |
|
21 Coronavirus epidemic and its social/mental dimensions: the Turkey case |
|
|
423 | (10) |
|
|
|
423 | (3) |
|
2 Looting culture and perspectives with phenomenology |
|
|
426 | (1) |
|
3 Unethical criminal and the "produced anxiety"® |
|
|
427 | (2) |
|
4 Self-ostracism® and the coronavirus hallucination |
|
|
429 | (1) |
|
5 Political structure of the coronavirus and the cultural racism |
|
|
430 | (1) |
|
6 Conclusion: Foucault, "big locking down," and "the world is a great madhouse" |
|
|
431 | (2) |
|
|
431 | (2) |
|
22 Coronavirus: a scientometric study of worldwide research publications |
|
|
433 | (16) |
|
|
|
Balabhim Sankrappa Biradar |
|
|
|
|
433 | (1) |
|
|
434 | (1) |
|
|
435 | (9) |
|
|
444 | (2) |
|
|
446 | (3) |
|
|
447 | (2) |
|
23 The effects of COVID-19 pandemic on Western Balkan financial markets |
|
|
449 | (16) |
|
|
|
449 | (1) |
|
|
450 | (2) |
|
|
452 | (1) |
|
4 The effects of globalization |
|
|
452 | (1) |
|
|
453 | (4) |
|
|
457 | (1) |
|
|
458 | (7) |
|
|
458 | (5) |
|
|
463 | (2) |
|
24 Prioritization of health emergency research and disaster preparedness: a systematic assessment of the coronavirus disease 2019 pandemic |
|
|
465 | (22) |
|
|
|
|
|
|
465 | (2) |
|
|
467 | (1) |
|
3 Evaluation of collaboration network in health emergency research |
|
|
467 | (2) |
|
|
469 | (1) |
|
|
469 | (13) |
|
|
482 | (1) |
|
|
483 | (4) |
|
|
484 | (1) |
|
|
484 | (1) |
|
Appendix A Supplementary data |
|
|
484 | (1) |
|
|
484 | (3) |
|
25 A review on epidemiology, genomic characteristics, spread, and treatments of COVID-19 |
|
|
487 | (20) |
|
|
|
M. Rubaiyat Hossain Mondal |
|
|
|
|
|
487 | (2) |
|
|
489 | (1) |
|
3 Epidemiology of coronavirus |
|
|
490 | (1) |
|
|
490 | (1) |
|
|
491 | (1) |
|
|
492 | (1) |
|
7 Statistical analysis on COVID-19 |
|
|
492 | (3) |
|
8 Clinical features of COVID-19 |
|
|
495 | (3) |
|
|
498 | (1) |
|
|
499 | (1) |
|
|
500 | (7) |
|
|
500 | (7) |
|
26 Control of antibiotic resistance and superinfections as a strategy to manage COVID-19 deaths |
|
|
507 | (24) |
|
|
|
|
|
|
|
507 | (1) |
|
2 Effect of superinfections on immune response and the severity of COVID-19 infection |
|
|
508 | (3) |
|
3 Antibiotic resistance as a challenge in the COVID-19 pandemic |
|
|
511 | (2) |
|
4 Alternative treatment strategies to overcome antibiotic resistance as a contributor to COVID-19 deaths |
|
|
513 | (5) |
|
5 Mouthwashes as an early preventive strategy |
|
|
518 | (13) |
|
|
520 | (11) |
|
27 Assessment of global research trends in the application of data science and deep and machine learning to the COVID-19 pandemic |
|
|
531 | (16) |
|
|
|
|
|
|
|
|
|
531 | (1) |
|
|
532 | (2) |
|
|
534 | (10) |
|
|
544 | (3) |
|
|
545 | (2) |
|
28 Identification of lead inhibitors of TMPRSS2 isoform 1 of SARS-CoV-2 target using neural network, random forest, and molecular docking |
|
|
547 | (30) |
|
Alakanse Suleiman Oluwaseun |
|
|
|
|
|
Sulaiman Faoziyat Adenike |
|
|
Ohanaka Judith Nkechinyere |
|
|
|
|
Olarewaju Ayodeji Durojaye |
|
|
|
547 | (1) |
|
|
548 | (3) |
|
|
551 | (26) |
|
|
572 | (5) |
|
29 The linkage between the epidemic of COVID-19 and oil prices: case of Saudi Arabia, January 22 to April 17 |
|
|
577 | (12) |
|
Said Khalfa Mokhtar Brika |
|
|
|
|
|
|
577 | (1) |
|
|
578 | (1) |
|
3 Coronavirus: pandemic scaring the world |
|
|
579 | (2) |
|
|
581 | (4) |
|
5 Conclusion and recommendation |
|
|
585 | (4) |
|
|
585 | (1) |
|
|
586 | (1) |
|
|
586 | (1) |
|
|
586 | (3) |
|
30 Role of big geospatial data in the COVID-19 crisis |
|
|
589 | (22) |
|
|
|
|
|
|
589 | (2) |
|
|
591 | (1) |
|
|
591 | (2) |
|
4 GeoAI: geospatial artificial intelligence and health geographies |
|
|
593 | (1) |
|
5 Big geospatial data and infectious disease pattern |
|
|
594 | (5) |
|
6 Case studies of China and Taiwan |
|
|
599 | (4) |
|
7 Results and discussions |
|
|
603 | (3) |
|
|
606 | (5) |
|
|
606 | (5) |
|
31 COVID-19: will it be a game changer in higher education in India? |
|
|
611 | (20) |
|
|
|
|
|
|
|
611 | (2) |
|
2 Proposed basic learning model |
|
|
613 | (3) |
|
3 COVID-19: challenges in Indian education |
|
|
616 | (2) |
|
|
618 | (4) |
|
|
622 | (3) |
|
|
625 | (6) |
|
|
626 | (5) |
|
32 Are the northern and southern regions equally affected by the COVID-19 pandemic? An empirical evidence from Nigeria |
|
|
631 | (16) |
|
|
|
|
631 | (5) |
|
|
636 | (3) |
|
|
639 | (3) |
|
4 Conclusion and recommendation |
|
|
642 | (5) |
|
|
643 | (4) |
|
33 COVID-19 lethality reduction using artificial intelligence solutions derived from telecommunications systems |
|
|
647 | (20) |
|
|
|
|
647 | (2) |
|
|
649 | (5) |
|
3 European Telecommunications Standards Institute architecture |
|
|
654 | (4) |
|
4 Data required to reduce COVID lethality |
|
|
658 | (2) |
|
5 Adaptation of the European Telecommunications Standards Institute architecture to the needs of public services |
|
|
660 | (4) |
|
|
664 | (3) |
|
|
664 | (3) |
|
34 The significance of daily incidence and mortality cases due to COVID-19 in some African countries |
|
|
667 | (14) |
|
|
|
Akinola Oladiran Adepetun |
|
|
Olubukola Olayemi Olusola-Makinde |
|
|
|
|
667 | (2) |
|
|
669 | (1) |
|
|
670 | (4) |
|
|
674 | (3) |
|
|
677 | (4) |
|
|
678 | (3) |
|
35 Data interpretation leading to image processing: a hybrid perspective to a global pandemic, COVID-19 |
|
|
681 | (24) |
|
|
|
|
|
|
|
|
681 | (2) |
|
|
683 | (1) |
|
|
684 | (4) |
|
|
688 | (4) |
|
5 Image processing analysis |
|
|
692 | (2) |
|
|
694 | (1) |
|
7 Conclusion and future work |
|
|
695 | (10) |
|
Appendix A Country-wise coronavirus details |
|
|
695 | (6) |
|
|
701 | (4) |
|
36 COVID-19: in the direction of monitoring the pandemic in India |
|
|
705 | (24) |
|
|
|
|
|
|
705 | (1) |
|
2 Origin and mode of transmission of COVID-19 |
|
|
706 | (1) |
|
3 Clinical characteristics of COVID-19 |
|
|
707 | (2) |
|
4 Current scenario of COVID-19 in India |
|
|
709 | (3) |
|
5 Precautions taken in India for controlling COVID-19 spread |
|
|
712 | (11) |
|
6 Problems faced in controlling COVID-19 spread |
|
|
723 | (1) |
|
7 Significance and outcomes of the adopted measures |
|
|
724 | (2) |
|
|
726 | (1) |
|
|
727 | (2) |
|
|
727 | (1) |
|
|
727 | (2) |
|
37 Potential antiviral therapies for coronavirus disease 2019 (COVID-19) |
|
|
729 | (16) |
|
|
|
|
729 | (2) |
|
|
731 | (2) |
|
3 Epidemiology and clinical features |
|
|
733 | (1) |
|
4 Potential antiviral therapies under consideration |
|
|
734 | (10) |
|
5 Conclusion and future work |
|
|
744 | (1) |
References |
|
745 | (4) |
Index |
|
749 | |